Related Experiment Video
Updated: Oct 18, 2025
A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
Published on: May 27, 2021
Exploring Candidate Human Synthetic Lethal Interactions Through siRNA and Quantitative Imaging-Based Approaches
Lucile M Jeusset1,2, Kirk J McManus3,4
1CancerCare Manitoba Research Institute, CancerCare Manitoba, Winnipeg, MB, Canada.
Abstract:
Synthetic lethal interactions can assist in characterizing protein functions and cellular processes, but they can also be used to identify novel drug targets for the development of innovative cancer therapeutic strategies. Despite recent technological advancements including CRISPR/Cas9 approaches, the systematic assessment of all pairwise gene interactions in humans (~ 200 million pairs) remains an unmet goal. Thus, hypothesis-driven approaches, which prioritize subsets of promising candidate SL interactions for experimental assessment, are critical to expedite the identification of novel SL interactions. Here, we provide a guide to screen and validate focused libraries of promising candidate SL interactions, typically consisting of 50-500 targets. First, we describe two siRNA and image-based screening protocols to rapidly assess candidate SL interactions. Subsequently, we provide methods to validate a subset of the most promising interactions uncovered in the screens. These approaches employ commercially available reagents and standard laboratory equipment to facilitate and expedite the identification of bona fide human SL interactions.
Insights
This study presents a guide for identifying synthetic lethal (SL) interactions, crucial for understanding cellular processes and discovering new cancer drug targets. It details methods for screening and validating SL interactions to accelerate therapeutic development.
Area of Science:
- Genetics and Genomics
- Cancer Biology
- Drug Discovery
Background:
- Synthetic lethal (SL) interactions offer insights into protein function and cellular pathways.
- SL interactions are valuable for identifying novel cancer therapeutic targets.
- Current high-throughput methods struggle to assess all human gene pairs (~200 million).
Purpose of the Study:
- To provide a practical guide for screening and validating focused libraries of candidate SL interactions.
- To expedite the discovery of bona fide human SL interactions.
- To facilitate hypothesis-driven approaches for prioritizing SL interactions.
Main Methods:
- Describes two siRNA and image-based screening protocols for rapid assessment of candidate SL interactions.
- Outlines methods for validating promising SL interactions identified through screening.
- Utilizes commercially available reagents and standard laboratory equipment.
Main Results:
- The described protocols enable rapid assessment of candidate SL interactions.
- Validation methods confirm the identified SL interactions.
- The approach facilitates the identification of bona fide human SL interactions.
Conclusions:
- Focused screening and validation of SL interactions accelerate the discovery of novel therapeutic targets.
- This guide provides accessible methods for researchers to identify SL interactions.
- The findings contribute to the development of innovative cancer therapeutic strategies.
